Copyright Reports & Markets. All rights reserved.

Global Oxaliplatin Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Oxaliplatin Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Oxaliplatin Market Size Growth Rate by Type
    • 1.2.2 Mannitol
    • 1.2.3 Glucose Solution
    • 1.2.4 Lactose Solution
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Oxaliplatin Market Size Growth Rate by Application
    • 1.3.2 Colorectal Cancer
    • 1.3.3 Stomach Cancer
    • 1.3.4 Ovarian Cancer
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Oxaliplatin Market Size Estimates and Forecasts
    • 2.1.1 Global Oxaliplatin Revenue 2015-2026
    • 2.1.2 Global Oxaliplatin Sales 2015-2026
  • 2.2 Oxaliplatin Market Size by Region: 2020 Versus 2026
  • 2.3 Oxaliplatin Sales by Region (2015-2026)
    • 2.3.1 Global Oxaliplatin Sales by Region: 2015-2020
    • 2.3.2 Global Oxaliplatin Sales Forecast by Region (2021-2026)
    • 2.3.3 Global Oxaliplatin Sales Market Share by Region (2015-2026)
  • 2.4 Oxaliplatin Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Oxaliplatin Revenue by Region: 2015-2020
    • 2.4.2 Global Oxaliplatin Revenue Forecast by Region (2021-2026)
    • 2.4.3 Global Oxaliplatin Revenue Market Share by Region (2015-2026)

3 Global Oxaliplatin by Manufacturers

  • 3.1 Global Top Oxaliplatin Manufacturers by Sales
    • 3.1.1 Global Oxaliplatin Sales by Manufacturer (2015-2020)
    • 3.1.2 Global Oxaliplatin Sales Market Share by Manufacturer (2015-2019)
  • 3.2 Global Top Oxaliplatin Manufacturers by Revenue
    • 3.2.1 Global Oxaliplatin Revenue by Manufacturer (2015-2020)
    • 3.2.2 Global Oxaliplatin Revenue Share by Manufacturer (2015-2020)
  • 3.3 Global Oxaliplatin Price by Manufacturer (2015-2020)
  • 3.4 Competitive Landscape
    • 3.4.1 Key Oxaliplatin Manufacturers Covered: Ranking by Revenue
    • 3.4.2 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI) & (2015-2020)
    • 3.4.3 Global Oxaliplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.5 Global Oxaliplatin Manufacturing Base Distribution, Product Type
    • 3.5.1 Oxaliplatin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.5.2 Manufacturers Oxaliplatin Product Type
    • 3.5.3 Date of International Manufacturers Enter into Oxaliplatin Market
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

  • 4.1 Sanofi-Aventis
    • 4.1.1 Sanofi-Aventis Corporation Information
    • 4.1.2 Sanofi-Aventis Description, Business Overview
    • 4.1.3 Sanofi-Aventis Oxaliplatin Products Offered
    • 4.1.4 Sanofi-Aventis Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.1.5 Sanofi-Aventis Oxaliplatin Revenue by Product
    • 4.1.6 Sanofi-Aventis Oxaliplatin Revenue by Application
    • 4.1.7 Sanofi-Aventis Oxaliplatin Revenue by Geographic Area
    • 4.1.8 Sanofi-Aventis Oxaliplatin Revenue by Sales Channel
    • 4.1.9 Sanofi-Aventis Recent Development
  • 4.2 Yakult honsha
    • 4.2.1 Yakult honsha Corporation Information
    • 4.2.2 Yakult honsha Description, Business Overview
    • 4.2.3 Yakult honsha Oxaliplatin Products Offered
    • 4.2.4 Yakult honsha Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.2.5 Yakult honsha Oxaliplatin Revenue by Product
    • 4.2.6 Yakult honsha Oxaliplatin Revenue by Application
    • 4.2.7 Yakult honsha Oxaliplatin Revenue by Geographic Area
    • 4.2.8 Yakult honsha Oxaliplatin Revenue by Sales Channel
    • 4.2.9 Yakult honsha Recent Development
  • 4.3 Dr Reddy's laboratories
    • 4.3.1 Dr Reddy's laboratories Corporation Information
    • 4.3.2 Dr Reddy's laboratories Description, Business Overview
    • 4.3.3 Dr Reddy's laboratories Oxaliplatin Products Offered
    • 4.3.4 Dr Reddy's laboratories Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.3.5 Dr Reddy's laboratories Oxaliplatin Revenue by Product
    • 4.3.6 Dr Reddy's laboratories Oxaliplatin Revenue by Application
    • 4.3.7 Dr Reddy's laboratories Oxaliplatin Revenue by Geographic Area
    • 4.3.8 Dr Reddy's laboratories Oxaliplatin Revenue by Sales Channel
    • 4.3.9 Dr Reddy's laboratories Recent Development
  • 4.4 Sun Pharmaceutical
    • 4.4.1 Sun Pharmaceutical Corporation Information
    • 4.4.2 Sun Pharmaceutical Description, Business Overview
    • 4.4.3 Sun Pharmaceutical Oxaliplatin Products Offered
    • 4.4.4 Sun Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.4.5 Sun Pharmaceutical Oxaliplatin Revenue by Product
    • 4.4.6 Sun Pharmaceutical Oxaliplatin Revenue by Application
    • 4.4.7 Sun Pharmaceutical Oxaliplatin Revenue by Geographic Area
    • 4.4.8 Sun Pharmaceutical Oxaliplatin Revenue by Sales Channel
    • 4.4.9 Sun Pharmaceutical Recent Development
  • 4.5 Teva
    • 4.5.1 Teva Corporation Information
    • 4.5.2 Teva Description, Business Overview
    • 4.5.3 Teva Oxaliplatin Products Offered
    • 4.5.4 Teva Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.5.5 Teva Oxaliplatin Revenue by Product
    • 4.5.6 Teva Oxaliplatin Revenue by Application
    • 4.5.7 Teva Oxaliplatin Revenue by Geographic Area
    • 4.5.8 Teva Oxaliplatin Revenue by Sales Channel
    • 4.5.9 Teva Recent Development
  • 4.6 Fresenius Kabi
    • 4.6.1 Fresenius Kabi Corporation Information
    • 4.6.2 Fresenius Kabi Description, Business Overview
    • 4.6.3 Fresenius Kabi Oxaliplatin Products Offered
    • 4.6.4 Fresenius Kabi Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.6.5 Fresenius Kabi Oxaliplatin Revenue by Product
    • 4.6.6 Fresenius Kabi Oxaliplatin Revenue by Application
    • 4.6.7 Fresenius Kabi Oxaliplatin Revenue by Geographic Area
    • 4.6.8 Fresenius Kabi Recent Development
  • 4.7 Hospira
    • 4.7.1 Hospira Corporation Information
    • 4.7.2 Hospira Description, Business Overview
    • 4.7.3 Hospira Oxaliplatin Products Offered
    • 4.7.4 Hospira Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.7.5 Hospira Oxaliplatin Revenue by Product
    • 4.7.6 Hospira Oxaliplatin Revenue by Application
    • 4.7.7 Hospira Oxaliplatin Revenue by Geographic Area
    • 4.7.8 Hospira Recent Development
  • 4.8 Mylan
    • 4.8.1 Mylan Corporation Information
    • 4.8.2 Mylan Description, Business Overview
    • 4.8.3 Mylan Oxaliplatin Products Offered
    • 4.8.4 Mylan Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.8.5 Mylan Oxaliplatin Revenue by Product
    • 4.8.6 Mylan Oxaliplatin Revenue by Application
    • 4.8.7 Mylan Oxaliplatin Revenue by Geographic Area
    • 4.8.8 Mylan Recent Development
  • 4.9 Jiangsu Hengrui Medicine
    • 4.9.1 Jiangsu Hengrui Medicine Corporation Information
    • 4.9.2 Jiangsu Hengrui Medicine Description, Business Overview
    • 4.9.3 Jiangsu Hengrui Medicine Oxaliplatin Products Offered
    • 4.9.4 Jiangsu Hengrui Medicine Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.9.5 Jiangsu Hengrui Medicine Oxaliplatin Revenue by Product
    • 4.9.6 Jiangsu Hengrui Medicine Oxaliplatin Revenue by Application
    • 4.9.7 Jiangsu Hengrui Medicine Oxaliplatin Revenue by Geographic Area
    • 4.9.8 Jiangsu Hengrui Medicine Recent Development
  • 4.10 Nanjing Pharmaceutical Factory
    • 4.10.1 Nanjing Pharmaceutical Factory Corporation Information
    • 4.10.2 Nanjing Pharmaceutical Factory Description, Business Overview
    • 4.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Products Offered
    • 4.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.10.5 Nanjing Pharmaceutical Factory Oxaliplatin Revenue by Product
    • 4.10.6 Nanjing Pharmaceutical Factory Oxaliplatin Revenue by Application
    • 4.10.7 Nanjing Pharmaceutical Factory Oxaliplatin Revenue by Geographic Area
    • 4.10.8 Nanjing Pharmaceutical Factory Recent Development
  • 4.11 Jiangsu Aosaikang Pharmaceutical
    • 4.11.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
    • 4.11.2 Jiangsu Aosaikang Pharmaceutical Description, Business Overview
    • 4.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Products Offered
    • 4.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.11.5 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue by Product
    • 4.11.6 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue by Application
    • 4.11.7 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue by Geographic Area
    • 4.11.8 Jiangsu Aosaikang Pharmaceutical Recent Development
  • 4.12 Qilu Pharmaceutical
    • 4.12.1 Qilu Pharmaceutical Corporation Information
    • 4.12.2 Qilu Pharmaceutical Description, Business Overview
    • 4.12.3 Qilu Pharmaceutical Oxaliplatin Products Offered
    • 4.12.4 Qilu Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.12.5 Qilu Pharmaceutical Oxaliplatin Revenue by Product
    • 4.12.6 Qilu Pharmaceutical Oxaliplatin Revenue by Application
    • 4.12.7 Qilu Pharmaceutical Oxaliplatin Revenue by Geographic Area
    • 4.12.8 Qilu Pharmaceutical Recent Development
  • 4.13 Hisun Pharmaceutical
    • 4.13.1 Hisun Pharmaceutical Corporation Information
    • 4.13.2 Hisun Pharmaceutical Description, Business Overview
    • 4.13.3 Hisun Pharmaceutical Oxaliplatin Products Offered
    • 4.13.4 Hisun Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.13.5 Hisun Pharmaceutical Oxaliplatin Revenue by Product
    • 4.13.6 Hisun Pharmaceutical Oxaliplatin Revenue by Application
    • 4.13.7 Hisun Pharmaceutical Oxaliplatin Revenue by Geographic Area
    • 4.13.8 Hisun Pharmaceutical Recent Development
  • 4.14 Lunan Pharmaceutical
    • 4.14.1 Lunan Pharmaceutical Corporation Information
    • 4.14.2 Lunan Pharmaceutical Description, Business Overview
    • 4.14.3 Lunan Pharmaceutical Oxaliplatin Products Offered
    • 4.14.4 Lunan Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.14.5 Lunan Pharmaceutical Oxaliplatin Revenue by Product
    • 4.14.6 Lunan Pharmaceutical Oxaliplatin Revenue by Application
    • 4.14.7 Lunan Pharmaceutical Oxaliplatin Revenue by Geographic Area
    • 4.14.8 Lunan Pharmaceutical Recent Development
  • 4.15 Luoxin
    • 4.15.1 Luoxin Corporation Information
    • 4.15.2 Luoxin Description, Business Overview
    • 4.15.3 Luoxin Oxaliplatin Products Offered
    • 4.15.4 Luoxin Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.15.5 Luoxin Oxaliplatin Revenue by Product
    • 4.15.6 Luoxin Oxaliplatin Revenue by Application
    • 4.15.7 Luoxin Oxaliplatin Revenue by Geographic Area
    • 4.15.8 Luoxin Recent Development
  • 4.16 Halfsky Pharmacy
    • 4.16.1 Halfsky Pharmacy Corporation Information
    • 4.16.2 Halfsky Pharmacy Description, Business Overview
    • 4.16.3 Halfsky Pharmacy Oxaliplatin Products Offered
    • 4.16.4 Halfsky Pharmacy Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.16.5 Halfsky Pharmacy Oxaliplatin Revenue by Product
    • 4.16.6 Halfsky Pharmacy Oxaliplatin Revenue by Application
    • 4.16.7 Halfsky Pharmacy Oxaliplatin Revenue by Geographic Area
    • 4.16.8 Halfsky Pharmacy Recent Development
  • 4.17 YRPG
    • 4.17.1 YRPG Corporation Information
    • 4.17.2 YRPG Description, Business Overview
    • 4.17.3 YRPG Oxaliplatin Products Offered
    • 4.17.4 YRPG Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.17.5 YRPG Oxaliplatin Revenue by Product
    • 4.17.6 YRPG Oxaliplatin Revenue by Application
    • 4.17.7 YRPG Oxaliplatin Revenue by Geographic Area
    • 4.17.8 YRPG Recent Development
  • 4.18 Hainan Jinrui Pharmaceutical
    • 4.18.1 Hainan Jinrui Pharmaceutical Corporation Information
    • 4.18.2 Hainan Jinrui Pharmaceutical Description, Business Overview
    • 4.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Products Offered
    • 4.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.18.5 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue by Product
    • 4.18.6 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue by Application
    • 4.18.7 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue by Geographic Area
    • 4.18.8 Hainan Jinrui Pharmaceutical Recent Development
  • 4.19 Jari Pharmaceutical
    • 4.19.1 Jari Pharmaceutical Corporation Information
    • 4.19.2 Jari Pharmaceutical Description, Business Overview
    • 4.19.3 Jari Pharmaceutical Oxaliplatin Products Offered
    • 4.19.4 Jari Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.19.5 Jari Pharmaceutical Oxaliplatin Revenue by Product
    • 4.19.6 Jari Pharmaceutical Oxaliplatin Revenue by Application
    • 4.19.7 Jari Pharmaceutical Oxaliplatin Revenue by Geographic Area
    • 4.19.8 Jari Pharmaceutical Recent Development
  • 4.20 Chiatai Tianqing
    • 4.20.1 Chiatai Tianqing Corporation Information
    • 4.20.2 Chiatai Tianqing Description, Business Overview
    • 4.20.3 Chiatai Tianqing Oxaliplatin Products Offered
    • 4.20.4 Chiatai Tianqing Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
    • 4.20.5 Chiatai Tianqing Oxaliplatin Revenue by Product
    • 4.20.6 Chiatai Tianqing Oxaliplatin Revenue by Application
    • 4.20.7 Chiatai Tianqing Oxaliplatin Revenue by Geographic Area
    • 4.20.8 Chiatai Tianqing Recent Development

5 Breakdown Data by Type

  • 5.1 Global Oxaliplatin Sales by Type (2015-2026)
    • 5.1.1 Global Oxaliplatin Sales by Type (2015-2020)
    • 5.1.2 Global Oxaliplatin Sales Forecast by Type (2021-2026)
    • 5.1.3 Global Oxaliplatin Sales Market Share by Type (2015-2026)
  • 5.2 Global Oxaliplatin Revenue Forecast by Type (2015-2026)
    • 5.2.1 Global Oxaliplatin Revenue by Type (2015-2020)
    • 5.2.2 Global Oxaliplatin Revenue Forecast by Type (2021-2026)
    • 5.2.3 Global Oxaliplatin Revenue Market Share by Type (2015-2026)
  • 5.3 Oxaliplatin Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

  • 6.1 Global Oxaliplatin Sales by Application (2015-2026)
    • 6.1.1 Global Oxaliplatin Sales by Application (2015-2020)
    • 6.1.2 Global Oxaliplatin Sales Forecast by Application (2021-2026)
    • 6.1.3 Global Oxaliplatin Sales Market Share by Application (2015-2026)
  • 6.2 Global Oxaliplatin Revenue Forecast by Application (2015-2026)
    • 6.2.1 Global Oxaliplatin Revenue by Application (2015-2020)
    • 6.2.2 Global Oxaliplatin Revenue Forecast by Application (2021-2026)
    • 6.2.3 Global Oxaliplatin Revenue Market Share by Application (2015-2026)
  • 6.3 Oxaliplatin Average Selling Price (ASP) by Application (2015-2026)

7 North America

  • 7.1 North America Oxaliplatin Market Size YoY Growth 2015-2026
  • 7.2 North America Oxaliplatin Market Facts & Figures by Country
    • 7.2.1 North America Oxaliplatin Sales by Country (2015-2026)
    • 7.2.2 North America Oxaliplatin Revenue by Country (2015-2026)
  • 7.3 North America Oxaliplatin Sales by Type
  • 7.4 North America Oxaliplatin Sales by Application

8 Asia-Pacific

  • 8.1 Asia-Pacific Oxaliplatin Market Size YoY Growth 2015-2026
  • 8.2 Asia-Pacific Oxaliplatin Market Facts & Figures by Region
    • 8.2.1 Asia-Pacific Oxaliplatin Sales by Region (2015-2026)
    • 8.2.2 Asia-Pacific Oxaliplatin Revenue by Region (2015-2026)
  • 8.3 Asia-Pacific Oxaliplatin Sales by Type
  • 8.4 Asia-Pacific Oxaliplatin Sales by Application

9 Europe

  • 9.1 Europe Oxaliplatin Market Size YoY Growth 2015-2026
  • 9.2 Europe Oxaliplatin Market Facts & Figures by Country
    • 9.2.1 Europe Oxaliplatin Sales by Country (2015-2026)
    • 9.2.2 Europe Oxaliplatin Revenue by Country (2015-2026)
  • 9.3 Europe Oxaliplatin Sales by Type
  • 9.4 Europe Oxaliplatin Sales by Application

10 Latin America

  • 10.1 Latin America Oxaliplatin Market Size YoY Growth 2015-2026
  • 10.2 Latin America Oxaliplatin Market Facts & Figures by Country
    • 10.2.1 Latin America Oxaliplatin Sales by Country (2015-2026)
    • 10.2.2 Latin America Oxaliplatin Revenue by Country (2015-2026)
  • 10.3 Latin America Oxaliplatin Sales by Type
  • 10.4 Latin America Oxaliplatin Sales by Application

11 Middle East and Africa

  • 11.1 Middle East and Africa Oxaliplatin Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Oxaliplatin Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Oxaliplatin Sales by Country (2015-2026)
    • 11.2.2 Middle East and Africa Oxaliplatin Revenue by Country (2015-2026)
  • 11.3 Middle East and Africa Oxaliplatin Sales by Type
  • 11.4 Middle East and Africa Oxaliplatin Sales by Application

12 Supply Chain and Sales Channel Analysis

  • 12.1 Oxaliplatin Supply Chain Analysis
  • 12.2 Oxaliplatin Key Raw Materials and Upstream Suppliers
  • 12.3 Oxaliplatin Clients Analysis
  • 12.4 Oxaliplatin Sales Channel and Sales Model Analysis
    • 12.4.1 Oxaliplatin Distribution Channel Analysis: Indirect Sales VS Direct Sales
    • 12.4.2 Oxaliplatin Distribution Channel Analysis: Online Sales VS Offline Sales
    • 12.4.3 Oxaliplatin Distributors

13 Market Dynamics

  • 13.1 Oxaliplatin Market Drivers
  • 13.2 Oxaliplatin Market Opportunities
  • 13.3 Oxaliplatin Market Challenges
  • 13.4 Oxaliplatin Market Restraints
  • 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Oxaliplatin market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Oxaliplatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

    Segment by Type, the Oxaliplatin market is segmented into
    Mannitol
    Glucose Solution
    Lactose Solution
    Other

    Segment by Application, the Oxaliplatin market is segmented into
    Colorectal Cancer
    Stomach Cancer
    Ovarian Cancer
    Other

    Regional and Country-level Analysis:
    North America
    United States
    Canada
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Southeast Asia
    Australia
    Rest of Asia-Pacific
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic Countries
    Rest of Europe
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    Competitive Landscape and Oxaliplatin Market Share Analysis
    Oxaliplatin market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Oxaliplatin product introduction, recent developments, Oxaliplatin sales by region, type, application and by sales channel.

    The major companies include:
    Sanofi-Aventis
    Yakult honsha
    Dr Reddy's laboratories
    Sun Pharmaceutical
    Teva
    Fresenius Kabi
    Hospira
    Mylan
    Jiangsu Hengrui Medicine
    Nanjing Pharmaceutical Factory
    Jiangsu Aosaikang Pharmaceutical
    Qilu Pharmaceutical
    Hisun Pharmaceutical
    Lunan Pharmaceutical
    Luoxin
    Halfsky Pharmacy
    YRPG
    Hainan Jinrui Pharmaceutical
    Jari Pharmaceutical
    Chiatai Tianqing

    Buy now